Home › Mieloma multiplo › Iowa › Cedar Rapids
Studi clinici su Mieloma multiplo a Cedar Rapids, IA
15 studi su Mieloma multiplo cercano partecipanti presso sedi a Cedar Rapids e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 3
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi di distanza
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
In reclutamentoFase 1
- Research Site, Iowa City · a 25 mi di distanza
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 3
- University of Iowa Hospital and Clinics, Iowa City · a 25 mi di distanza
Collection of Tissue Samples for Cancer Research
In reclutamentoStudio osservazionale
- University of Iowa, Iowa City · a 25 mi di distanza
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 2
- University of Iowa, Iowa City · a 25 mi di distanza
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
In reclutamentoFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
In reclutamentoFase 1/2
- Research Site, Iowa City · a 25 mi di distanza
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
In reclutamentoFase 3
- Research Site, Iowa City · a 25 mi di distanza
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
In reclutamentoFase 2
- University of Iowa, Iowa City · a 25 mi di distanza
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
In reclutamentoFase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
In reclutamentoFase 2
- University of Iowa, Iowa City · a 25 mi di distanza
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
In reclutamentoFase 1
- University of Iowa Health Care, Iowa City · a 25 mi di distanza
Sleep Apnea in Patients With MGUS and MM
In reclutamentoStudio osservazionale
- University of Iowa, Iowa City · a 25 mi di distanza
Activity Levels in Bone Marrow Transplant Patients
In reclutamentoStudio osservazionale
- University of Iowa, Iowa City · a 25 mi di distanza
Limited-duration Teclistamab
In reclutamentoFase 2
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi di distanza
Studi su Mieloma multiplo in altre città
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Altri studi a Cedar Rapids
- Cancro del polmone non a piccole cellule20 studi
- Cancro al seno17 studi
- Leucemia mieloide acuta16 studi
- Cancro (tutti i tipi)15 studi
- Cancro ai polmoni14 studi
- Cancro colorettale13 studi
- Cancro alla prostata12 studi
- Carcinoma a cellule squamose della testa e del collo12 studi
- Melanoma10 studi
- Ictus10 studi
- Cancro metastatico9 studi
- Cancro dell'endometrio9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.